<?xml version="1.0" encoding="iso-8859-1" ?>
<newsitem itemid="479659" id="root" date="1997-04-01" xml:lang="en">
<title>USA: Aprogenex Q4 shr loss $0.12 vs loss $0.22.</title>
<headline>Aprogenex Q4 shr loss $0.12 vs loss $0.22.</headline>
<dateline>HOUSTON 1997-04-01</dateline>
<text>
<p>Aprogenex Inc</p>
<p>			   (A Development Stage Company)</p>
<p>				 Results of Operations</p>
<p>						For the Quarter Ended</p>
<p>					   December 31, (unaudited)</p>
<p>					     1996		  1995</p>
<p> Revenues				$16,659	     $12,924</p>
<p>Research and development</p>
<p>  expenses			   (315,888)	   (999,339)</p>
<p>Selling, general and</p>
<p>  administrative expenses	(227,198)	   (253,433)</p>
<p> Other, net			   (85,786)		76,180</p>
<p> Net loss			    (612,212)	 (1,163,668)</p>
<p> Net loss per Common share	   (.12)		 (.22)</p>
<p>Shares used in computing net</p>
<p>  loss per Common share	  5,201,681	   5,155,397</p>
<p>					 For the Twelve Months Ended</p>
<p>						    December 31,</p>
<p>					     1996		  1995</p>
<p> Revenues				$63,115	     $38,644</p>
<p>Research and development</p>
<p>  expenses			 (1,825,571)	 (3,496,538)</p>
<p>Selling, general and</p>
<p>  administrative expenses    (1,049,971)	 (1,925,742)</p>
<p> Other, net			  (125,834)	     106,850</p>
<p> Net loss			  (2,938,261)	 (5,276,786)</p>
<p> Net loss per Common share	   (.57)		(1.04)</p>
<p>Shares used in computing net</p>
<p>  loss per Common share	  5,195,562	   5,070,493</p>
<p>				Balance Sheet Highlights</p>
<p>						(Unaudited)</p>
<p>							As of</p>
<p>						     Dec 31,</p>
<p>							 1996</p>
<p> Cash and marketable securities	   $327,400</p>
<p> Current assets				  443,055</p>
<p> Current liabilities			   463,951</p>
<p>Convertible notes payable,</p>
<p>  including accrued interest	     2,069,126</p>
<p> Stockholders' equity		    (1,379,111)</p>
<p>Shares of Common Stock issued</p>
<p>  and oustanding			     5,225,498</p>
<p>Shares of Series A Convertible</p>
<p>Preferred Stock issued and</p>
<p>  outstanding				    444,000</p>
<p>Shares of Common Stock issued</p>
<p>and outstanding, assuming</p>
<p>conversion of Series A Convertible</p>
<p>Preferred Stocks and Convertible</p>
<p>  Notes					  9,362,982</p>
<p>-- New York Newsdesk 212 859-1610</p>
</text>
<copyright>(c) Reuters Limited 1997</copyright>
<metadata>
<codes class="bip:countries:1.0">
  <code code="USA">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-04-01"/>
  </code>
</codes>
<codes class="bip:industries:1.0">
  <code code="I25700">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-04-01"/>
  </code>
</codes>
<codes class="bip:topics:1.0">
  <code code="C15">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-04-01"/>
  </code>
  <code code="C151">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-04-01"/>
  </code>
  <code code="C1511">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-04-01"/>
  </code>
  <code code="CCAT">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-04-01"/>
  </code>
</codes>
<dc element="dc.date.created" value="1997-04-01"/>
<dc element="dc.publisher" value="Reuters Holdings Plc"/>
<dc element="dc.date.published" value="1997-04-01"/>
<dc element="dc.source" value="Reuters"/>
<dc element="dc.creator.location" value="HOUSTON"/>
<dc element="dc.creator.location.country.name" value="USA"/>
<dc element="dc.source" value="Reuters"/>
</metadata>
</newsitem>
